Epione Medicine ApS — Credit Rating and Financial Key Figures
CVR number: 41812052
Kanalholmen 14 L, 2650 Hvidovre
E.Johannsen@EpioneMedicine.com
tel: 71809864
Epionemedicine.com
Income statement (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | - 336.92 | 2 307.03 | 2 580.42 |
| Employee benefit expenses | -9.21 | - 686.09 | -2 448.40 |
| Total depreciation | -58.05 | - 247.25 | - 395.88 |
| EBIT | - 404.17 | 1 373.70 | - 263.86 |
| Other financial income | 2.71 | 7.62 | |
| Other financial expenses | -63.16 | - 340.82 | - 549.78 |
| Pre-tax profit | - 464.62 | 1 040.50 | - 813.63 |
| Income taxes | 101.86 | - 230.38 | 165.00 |
| Net earnings | - 362.76 | 810.11 | - 648.63 |
Assets (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Intangible rights | 271.85 | 447.55 | 714.94 |
| Intangible assets total | 271.85 | 447.55 | 714.94 |
| Buildings | 10.80 | ||
| Machinery and equipment | 40.47 | 105.75 | 360.54 |
| Tangible assets total | 51.28 | 105.75 | 360.54 |
| Other receivables | 65.55 | 30.55 | 30.55 |
| Investments total | 65.55 | 30.55 | 30.55 |
| Long term receivables total | |||
| Raw materials and consumables | 158.01 | 607.02 | 1 993.17 |
| Finished products/goods | 303.93 | 599.78 | 1 070.99 |
| Inventories total | 461.94 | 1 206.80 | 3 064.15 |
| Current trade debtors | 206.79 | 660.29 | 4 275.76 |
| Prepayments and accrued income | 66.50 | 183.01 | 108.26 |
| Current other receivables | 31.34 | ||
| Current deferred tax assets | 101.86 | 75.00 | |
| Short term receivables total | 406.49 | 843.30 | 4 459.02 |
| Cash and bank deposits | 1 690.27 | ||
| Cash and cash equivalents | 1 690.27 | ||
| Balance sheet total (assets) | 1 257.10 | 4 324.22 | 8 629.21 |
Equity and liabilities (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Share capital | 353.00 | 353.00 | 353.00 |
| Share premium account | 27.01 | ||
| Shares repurchased | 150.00 | ||
| Retained earnings | - 485.76 | 324.36 | |
| Profit of the financial year | - 362.76 | 810.11 | - 648.63 |
| Shareholders equity total | 17.24 | 827.36 | 28.72 |
| Provisions | 90.00 | ||
| Non-current other liabilities | 769.19 | ||
| Non-current deferred tax liabilities | 621.81 | 1 104.05 | |
| Non-current liabilities total | 769.19 | 621.81 | 1 104.05 |
| Current loans from credit institutions | 167.79 | 100.00 | 2 798.56 |
| Current trade creditors | 106.16 | 1 125.78 | 1 851.67 |
| Short-term deferred tax liabilities | 38.52 | ||
| Other non-interest bearing current liabilities | 196.71 | 1 520.75 | 2 846.21 |
| Current liabilities total | 470.66 | 2 785.05 | 7 496.44 |
| Balance sheet total (liabilities) | 1 257.10 | 4 324.22 | 8 629.21 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.